Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
481.79
+7.33 (1.54%)
Sep 16, 2025, 2:50 PM EDT - Market open
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.86B in the quarter ending June 28, 2025, with 2.98% growth. This brings the company's revenue in the last twelve months to $43.21B, up 2.05% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.21B
Revenue Growth
+2.05%
P/S Ratio
4.17
Revenue / Employee
$345,696
Employees
125,000
Market Cap
181.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TMO News
- 22 hours ago - Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel - Business Wire
- 1 day ago - Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance - Business Wire
- 10 days ago - Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript) - Seeking Alpha
- 14 days ago - Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site - Business Wire
- 14 days ago - Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. - PRNewsWire
- 14 days ago - Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business - Business Wire
- 18 days ago - Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025 - Business Wire
- 19 days ago - Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies - Business Wire